[144] Astera Labs, Inc. SEC Filing
Astera Labs, Inc. (ALAB) filed a Form 144 notifying a proposed sale of 100,000 common shares with an aggregate market value of $19,118,990. The shares are to be sold on NASDAQ around 08/12/2025 through Morgan Stanley Smith Barney LLC. The filing lists 166,219,140 shares outstanding, so the proposed sale equals approximately 0.06% of outstanding shares.
The securities were acquired as founder stock on 09/11/2020. The filing also discloses recent sales by TATE 1997 LIVING TRUST: three tranches on 08/07/2025 totaling 100,000 shares for combined gross proceeds of $17,138,480.00, and a 05/30/2025 sale of 500,000 shares for $45,098,194.00. The filer attests they do not know any undisclosed material adverse information.
Astera Labs, Inc. (ALAB) ha presentato un Form 144 notificando la proposta di vendita di 100,000 azioni ordinarie per un valore di mercato complessivo di $19,118,990. Le azioni saranno vendute sul NASDAQ intorno al 08/12/2025 tramite Morgan Stanley Smith Barney LLC. La comunicazione riporta 166,219,140 azioni in circolazione, quindi la vendita proposta corrisponde a circa il 0.06% del capitale sociale.
I titoli sono stati acquisiti come azioni di fondatore il 09/11/2020. La segnalazione segnala inoltre vendite recenti da parte del TATE 1997 LIVING TRUST: tre tranche il 08/07/2025 per un totale di 100,000 azioni con proventi lordi complessivi di $17,138,480.00, e una vendita il 05/30/2025 di 500,000 azioni per $45,098,194.00. Il dichiarante attesta di non essere a conoscenza di informazioni sfavorevoli rilevanti non divulgate.
Astera Labs, Inc. (ALAB) present贸 un Form 144 notificando la propuesta de venta de 100,000 acciones comunes por un valor de mercado agregado de $19,118,990. Las acciones se vender谩n en el NASDAQ alrededor del 08/12/2025 a trav茅s de Morgan Stanley Smith Barney LLC. La presentaci贸n indica 166,219,140 acciones en circulaci贸n, por lo que la venta propuesta equivale aproximadamente al 0.06% de las acciones en circulaci贸n.
Los valores fueron adquiridos como acciones de fundador el 09/11/2020. La presentaci贸n tambi茅n revela ventas recientes por parte de TATE 1997 LIVING TRUST: tres tramos el 08/07/2025 que suman 100,000 acciones por ingresos brutos combinados de $17,138,480.00, y una venta el 05/30/2025 de 500,000 acciones por $45,098,194.00. El declarante manifiesta que no tiene conocimiento de informaci贸n adversa material no divulgada.
Astera Labs, Inc. (ALAB)电� 100,000 氤错喌欤茧ゼ 齑� 鞁滌灔臧�旃� $19,118,990搿� 毵る弰頃� 鞓堨爼鞛勳潉 鞎岆Μ电� Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 08/12/2025瓴� NASDAQ鞚� 韱淀暣 Morgan Stanley Smith Barney LLC搿� 毵る弰霅� 鞓堨爼鞛呺媹雼�. 鞝滌稖靹滊鞐惖鐢 氚滍枆欤检嫕靾橁皜 166,219,140欤茧 旮办灛霅橃柎 鞛堨柎 鞝滌晥霅� 毵る弰电� 氚滍枆欤检嫕鞚� 鞎� 0.06%鞐� 頃措嫻頃╇媹雼�.
頃措嫻 歃濌秾鞚� 09/11/2020鞐� 彀届梾鞛� 欤检嫕鞙茧 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹湹鐢 霕愴暅 TATE 1997 LIVING TRUST鞚� 斓滉芳 毵る弰毳� 瓿店皽頃╇媹雼�: 08/07/2025鞐� 靹� 彀鞐� 瓯胳硱 齑� 100,000欤茧ゼ 毵る弰頃� 齑� 敫岆（韱� 靾橃澋 $17,138,480.00鞚� 鞏混棃瓿�, 05/30/2025鞐惖鐢 500,000欤茧ゼ 毵る弰頃� $45,098,194.00鞚� 靾橃澋鞚� 旮半頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞐� 雽�頃� 鞎劦鐢 氚� 鞐嗠嫟瓿� 歆勳垹頄堨姷雼堧嫟.
Astera Labs, Inc. (ALAB) a d茅pos茅 un formulaire 144 annon莽ant la proposition de vente de 100,000 actions ordinaires pour une valeur de march茅 totale de $19,118,990. Les actions doivent 锚tre vendues sur le NASDAQ aux alentours du 08/12/2025 via Morgan Stanley Smith Barney LLC. Le d茅p么t indique 166,219,140 actions en circulation, de sorte que la vente propos茅e repr茅sente environ 0.06% des actions en circulation.
Les titres ont 茅t茅 acquis en tant qu'actions de fondateur le 09/11/2020. Le dossier divulgue 茅galement des ventes r茅centes par le TATE 1997 LIVING TRUST : trois tranches le 08/07/2025 totalisant 100,000 actions pour un produit brut combin茅 de $17,138,480.00, et une vente le 05/30/2025 de 500,000 actions pour $45,098,194.00. Le d茅clarant atteste ne pas conna卯tre d'informations d茅favorables importantes non divulgu茅es.
Astera Labs, Inc. (ALAB) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 100.000 Stammaktien mit einem Gesamtmarktwert von $19,118,990 meldet. Die Aktien sollen etwa am 08/12/2025 眉产别谤 Morgan Stanley Smith Barney LLC an der NASDAQ verkauft werden. Die Einreichung weist 166,219,140 ausstehende Aktien aus, sodass der geplante Verkauf etwa 0.06% der ausstehenden Aktien entspricht.
Die Wertpapiere wurden am 09/11/2020 als 骋谤眉苍诲别谤补办迟颈别苍 erworben. Die Einreichung offenbart au脽erdem j眉ngste Verk盲ufe durch den TATE 1997 LIVING TRUST: drei Tranchen am 08/07/2025 mit insgesamt 100,000 Aktien f眉r kombinierte Bruttoerl枚se von $17,138,480.00 sowie einen Verkauf am 05/30/2025 von 500,000 Aktien f眉r $45,098,194.00. Der Einreicher best盲tigt, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
- None.
- None.
Insights
TL;DR: Routine insider notice; proposed 100,000-share sale is small relative to outstanding shares.
The Form 144 reports a planned sale of 100,000 common shares valued at $19,118,990, to be executed via Morgan Stanley Smith Barney on 08/12/2025. Against 166,219,140 shares outstanding, this equals ~0.06%, indicating limited dilution or direct market impact from this single transaction. The filing also lists recent trust sales totaling 600,000 shares across May and August 2025, which are disclosed separately. Overall impact: not material to capital structure or immediate valuation.
TL;DR: Filing meets Rule 144 notice requirements and includes standard attestation about material nonpublic information.
The notice identifies the shares as founder stock acquired on 09/11/2020 and includes the required attestation that the filer is unaware of undisclosed material adverse information. Broker and exchange details are provided. Prior open-market sales by a related trust are itemized, supporting transparency. This is a routine compliance disclosure rather than an extraordinary governance event.
Astera Labs, Inc. (ALAB) ha presentato un Form 144 notificando la proposta di vendita di 100,000 azioni ordinarie per un valore di mercato complessivo di $19,118,990. Le azioni saranno vendute sul NASDAQ intorno al 08/12/2025 tramite Morgan Stanley Smith Barney LLC. La comunicazione riporta 166,219,140 azioni in circolazione, quindi la vendita proposta corrisponde a circa il 0.06% del capitale sociale.
I titoli sono stati acquisiti come azioni di fondatore il 09/11/2020. La segnalazione segnala inoltre vendite recenti da parte del TATE 1997 LIVING TRUST: tre tranche il 08/07/2025 per un totale di 100,000 azioni con proventi lordi complessivi di $17,138,480.00, e una vendita il 05/30/2025 di 500,000 azioni per $45,098,194.00. Il dichiarante attesta di non essere a conoscenza di informazioni sfavorevoli rilevanti non divulgate.
Astera Labs, Inc. (ALAB) present贸 un Form 144 notificando la propuesta de venta de 100,000 acciones comunes por un valor de mercado agregado de $19,118,990. Las acciones se vender谩n en el NASDAQ alrededor del 08/12/2025 a trav茅s de Morgan Stanley Smith Barney LLC. La presentaci贸n indica 166,219,140 acciones en circulaci贸n, por lo que la venta propuesta equivale aproximadamente al 0.06% de las acciones en circulaci贸n.
Los valores fueron adquiridos como acciones de fundador el 09/11/2020. La presentaci贸n tambi茅n revela ventas recientes por parte de TATE 1997 LIVING TRUST: tres tramos el 08/07/2025 que suman 100,000 acciones por ingresos brutos combinados de $17,138,480.00, y una venta el 05/30/2025 de 500,000 acciones por $45,098,194.00. El declarante manifiesta que no tiene conocimiento de informaci贸n adversa material no divulgada.
Astera Labs, Inc. (ALAB)电� 100,000 氤错喌欤茧ゼ 齑� 鞁滌灔臧�旃� $19,118,990搿� 毵る弰頃� 鞓堨爼鞛勳潉 鞎岆Μ电� Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 08/12/2025瓴� NASDAQ鞚� 韱淀暣 Morgan Stanley Smith Barney LLC搿� 毵る弰霅� 鞓堨爼鞛呺媹雼�. 鞝滌稖靹滊鞐惖鐢 氚滍枆欤检嫕靾橁皜 166,219,140欤茧 旮办灛霅橃柎 鞛堨柎 鞝滌晥霅� 毵る弰电� 氚滍枆欤检嫕鞚� 鞎� 0.06%鞐� 頃措嫻頃╇媹雼�.
頃措嫻 歃濌秾鞚� 09/11/2020鞐� 彀届梾鞛� 欤检嫕鞙茧 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖靹湹鐢 霕愴暅 TATE 1997 LIVING TRUST鞚� 斓滉芳 毵る弰毳� 瓿店皽頃╇媹雼�: 08/07/2025鞐� 靹� 彀鞐� 瓯胳硱 齑� 100,000欤茧ゼ 毵る弰頃� 齑� 敫岆（韱� 靾橃澋 $17,138,480.00鞚� 鞏混棃瓿�, 05/30/2025鞐惖鐢 500,000欤茧ゼ 毵る弰頃� $45,098,194.00鞚� 靾橃澋鞚� 旮半頄堨姷雼堧嫟. 鞝滌稖鞚胳潃 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞐� 雽�頃� 鞎劦鐢 氚� 鞐嗠嫟瓿� 歆勳垹頄堨姷雼堧嫟.
Astera Labs, Inc. (ALAB) a d茅pos茅 un formulaire 144 annon莽ant la proposition de vente de 100,000 actions ordinaires pour une valeur de march茅 totale de $19,118,990. Les actions doivent 锚tre vendues sur le NASDAQ aux alentours du 08/12/2025 via Morgan Stanley Smith Barney LLC. Le d茅p么t indique 166,219,140 actions en circulation, de sorte que la vente propos茅e repr茅sente environ 0.06% des actions en circulation.
Les titres ont 茅t茅 acquis en tant qu'actions de fondateur le 09/11/2020. Le dossier divulgue 茅galement des ventes r茅centes par le TATE 1997 LIVING TRUST : trois tranches le 08/07/2025 totalisant 100,000 actions pour un produit brut combin茅 de $17,138,480.00, et une vente le 05/30/2025 de 500,000 actions pour $45,098,194.00. Le d茅clarant atteste ne pas conna卯tre d'informations d茅favorables importantes non divulgu茅es.
Astera Labs, Inc. (ALAB) hat ein Formular 144 eingereicht, das den geplanten Verkauf von 100.000 Stammaktien mit einem Gesamtmarktwert von $19,118,990 meldet. Die Aktien sollen etwa am 08/12/2025 眉产别谤 Morgan Stanley Smith Barney LLC an der NASDAQ verkauft werden. Die Einreichung weist 166,219,140 ausstehende Aktien aus, sodass der geplante Verkauf etwa 0.06% der ausstehenden Aktien entspricht.
Die Wertpapiere wurden am 09/11/2020 als 骋谤眉苍诲别谤补办迟颈别苍 erworben. Die Einreichung offenbart au脽erdem j眉ngste Verk盲ufe durch den TATE 1997 LIVING TRUST: drei Tranchen am 08/07/2025 mit insgesamt 100,000 Aktien f眉r kombinierte Bruttoerl枚se von $17,138,480.00 sowie einen Verkauf am 05/30/2025 von 500,000 Aktien f眉r $45,098,194.00. Der Einreicher best盲tigt, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
FAQ
What does the ALAB Form 144 report?
Who acquired the securities being sold?
How large is the proposed sale relative to shares outstanding for ALAB?
Were there recent related sales disclosed in the filing?
Does the filer state any undisclosed material information?
